Results 61 to 70 of about 3,062 (179)

Clinical Practice Guideline for Headache Disorders 2021

open access: yesNeurology and Clinical Neuroscience, Volume 13, Issue 6, Page 389-407, November 2025.
ABSTRACT The International Headache Society published the International Classification of Headache Disorders, 3rd edition in 2018. In this classification, Chapter 3—previously “Cluster headache and other trigeminal‐autonomic cephalalgias”—was renamed “Trigeminal‐autonomic cephalalgias (TACs).” Trigeminal‐autonomic cephalalgias are a group of disorders ...
Nobuo Araki   +10 more
wiley   +1 more source

Non‐Invasive Vagus Nerve Stimulation in Cluster Headache: A Clinical Practice Guideline

open access: yesPain Practice, Volume 25, Issue 8, November 2025.
ABSTRACT Background Cluster headache (CH) is a rare but severe primary headache disorder characterized by recurrent attacks of unilateral, typically periocular pain lasting 15 min to 3 h, accompanied by ipsilateral autonomic symptoms and restlessness or agitation.
Peter J. Goadsby   +4 more
wiley   +1 more source

Clinical application of transcutaneous auricular vagus nerve stimulation: a scoping review

open access: yesDisability and Rehabilitation
Transcutaneous auricular vagus nerve stimulation (taVNS) is an emerging non-invasive neuromodulation therapy. This study aimed to explore the therapeutic use of taVNS, optimal stimulation parameters, effective sham protocols, and safety.A scoping review was conducted. Five databases and grey literature were searched.
Ashraf N. H. Gerges   +6 more
openaire   +2 more sources

The effect of transcutaneous auricular vagus nerve stimulation on cardiovascular function in subarachnoid hemorrhage patients: A randomized trial [PDF]

open access: yes
BACKGROUND: Subarachnoid hemorrhage (SAH) is characterized by intense central inflammation, leading to substantial post-hemorrhagic complications such as vasospasm and delayed cerebral ischemia.
Adamek, Markus   +13 more
core   +2 more sources

Neuromodulators for Primary Headache Disorders: A Review [PDF]

open access: yes, 2020
Primary headache disorders are among the most common and disabling globally. Pharmacological treatments are often insufficient, poorly tolerated, have side effects and the majority of patients are unable to complete their treatment.
Demosthenous, A, Salkim, E
core  

Analyzing the Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation on Parkinson’s Disease Related Gait Function: A Systematic Review and Meta-Analysis [PDF]

open access: yes
Background: Those suffering from Parkinson’s Disease often experience a shuffling gait, alongside many other symptoms, due to the degradation of dopaminergic neurons in the substantia nigra.
Dakhel, Sami   +2 more
core   +2 more sources

Functional anatomy of the vagus system – Emphasis on the somato-visceral interface [PDF]

open access: yes, 2021
Due to its pivotal role in autonomic networks, the vagus attracts continuous interest from both basic scientists and clinicians. In particular, recent advances in vagus nerve stimulation strategies and their application to pathological conditions beyond ...
Berthoud, Hans Rudolf   +1 more
core   +1 more source

International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020). [PDF]

open access: yes, 2020
Given its non-invasive nature, there is increasing interest in the use of transcutaneous vagus nerve stimulation (tVNS) across basic, translational and clinical research.
Ackland, GL   +80 more
core  

No modulation of pupil size and event-related pupil response by transcutaneous auricular vagus nerve stimulation (taVNS) [PDF]

open access: yes, 2019
Transcutaneous auricular vagus nerve stimulation (taVNS) bears therapeutic potential for a wide range of medical conditions. However, previous studies have found substantial interindividual variability in responsiveness to taVNS, and no reliable ...
Demirezen, Mustafa   +4 more
core   +1 more source

CURRENT STATE OF KNOWLEDGE CONCERNING VAGUS NERVE STIMULATION IN TREATMENT OF MAJOR DEPRESSIVE DISORDER [PDF]

open access: yes
Introduction and aim: Vagus Nerve Stimulation (VNS), including its non-invasive form transcutaneous auricular VNS (taVNS), has emerged as a promising treatment for Major Depressive Disorder (MDD), particularly treatment-resistant cases.
Aleksandra Borowy   +9 more
core   +2 more sources

Home - About - Disclaimer - Privacy